5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation

5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation

Core Knowledge: Inhalation injury below the vocal cords is predominantly a chemical tracheobronchitis and parenchymal insult rather than a direct thermal burn. Toxic combustion byproducts dissolve in the airway lining fluid, destroying the pseudostratified ciliated epithelium, impairing the mucociliary escalator, and triggering a 10- to 20-fold surge in bronchial blood flow. The resulting protein-rich transudate, necrotic cellular debris, and fibrin mesh form thick, obstructing endobronchial casts. Management hinges on early diagnostic bronchoscopy, aggressive aerosolized pharmacotherapy (heparin/NAC/bronchodilators), and lung-protective mechanical ventilation to mitigate acute respiratory distress syndrome (ARDS).

---

Pathophysiology of Chemical Tracheobronchitis and Parenchymal Injury

When smoke enters the tracheobronchial tree, toxic gases (such as acrolein, formaldehyde, sulfur dioxide, hydrochloric acid, and phosgene) interact with mucosal moisture, forming concentrated acids and alkalis.

┌────────────────────────────────────────────────────────────────────────┐
│            LOWER AIRWAY CHEMICAL INHALATION INJURY CASCADE             │
│                                                                        │
│  Inhalation of Toxic Combustion Chemicals (Aldehydes, Acrolein, HCl)   │
│                                  │                                     │
│                                  ▼                                     │
│  Epithelial Necrosis & Loss of Pseudostratified Ciliated Cells         │
│  (Paralysis of Mucociliary Escalator & Loss of Surfactant)             │
│                                  │                                     │
│                                  ▼                                     │
│  Intense Neurogenic & Cytokine Inflammation (Substance P, IL-8, ROS)   │
│                                  │                                     │
│                                  ▼                                     │
│  Bronchial Microvascular Hyperemia (10x to 20x Increase in Blood Flow) │
│                                  │                                     │
│                                  ▼                                     │
│  Massive Transudation of Plasma Proteins, Fibrinogen & Neutrophils     │
│                                  │                                     │
│                                  ▼                                     │
│  Formation of Occlusive Endobronchial Fibrin-Cellular Casts            │
│                                  │                                     │
│         ┌────────────────────────┴────────────────────────┐            │
│         ▼                                                 ▼            │
│  Segmental Atelectasis & Air Trapping              Severe V/Q Mismatch │
│  (Secondary Bacterial Bronchopneumonia)            & Fulminant ARDS    │
└────────────────────────────────────────────────────────────────────────┘

1. Epithelial Destruction and Mucociliary Failure

The normal tracheobronchial tree is lined by pseudostratified ciliated columnar epithelium interspersed with goblet cells. Toxic chemicals denude this mucosal layer, causing cellular apoptosis, basement membrane separation, and immediate paralysis of the mucociliary escalator. Without functional cilia, the lung loses its primary mechanical clearance mechanism for inhaled particulates, bacteria, and sloughed cells.

2. Bronchial Hypervascularity and Transudation

Chemical irritation stimulates sensory C-fibers, releasing neuropeptides (substance P, calcitonin gene-related peptide) and triggering massive neutrophil recruitment. This generates an astonishing 10- to 20-fold increase in bronchial arterial blood flow. The hyperemic bronchial circulation leaks enormous quantities of plasma proteins, fluid, and fibrinogen into the airway lumen.

3. Cast Formation and Airway Obstruction

Within the airway lumen, extravasated fibrinogen encounters tissue factor, activating the coagulation cascade and polymerizing into a dense fibrin network. This fibrin mesh traps sloughed epithelial cells, neutrophils, mucus, and soot particulates, coalescing into thick, rubbery, branching bronchial casts.

• Pathological Consequences: These casts act as one-way ball-valves, causing distal hyperinflation and air trapping, or complete luminal obstruction leading to segmental and lobar atelectasis.
• V/Q Mismatch and Infection: Occluded lung segments suffer profound ventilation-perfusion (V/Q) mismatch and intrapulmonary shunting. Furthermore, non-viable cast material serves as a nutrient-rich culture medium for opportunistic pathogens (Pseudomonas aeruginosa, Staphylococcus aureus), dramatically increasing the incidence of bacterial bronchopneumonia.

---

Diagnostic Fiberoptic Bronchoscopy & AIS Grading

Fiberoptic bronchoscopy is the universally recognized gold standard for confirming the diagnosis, establishing baseline injury severity, and guiding therapeutic pulmonary toilet.

                    ┌─────────────────────────────────────────┐
                    │  ABBREVIATED INJURY SCORE (AIS) GRADING │
                    └────────────────────┬────────────────────┘
                                         │
         ┌───────────────────────────────┼───────────────────────────────┐
         ▼                               ▼                               ▼
┌──────────────────┐           ┌──────────────────┐           ┌──────────────────┐
│ GRADE 1: MILD    │           │ GRADE 2: MODERATE│           │ GRADE 3: SEVERE  │
│• Patchy erythema │           │• Marked erythema │           │• Severe ulceration
│• Carbon deposits │           │• Moderate edema  │           │• Deep necrosis   │
│• No ulceration   │           │• Copious mucus   │           │• Thick casts     │
└──────────────────┘           └──────────────────┘           └──────────────────┘
                                         │
                                         ▼
                               ┌──────────────────┐
                               │ GRADE 4: MASSIVE │
                               │• Complete slough │
                               │• Luminal closure │
                               │• True obstruction│
                               └──────────────────┘

The AIS Bronchoscopy Grading Scale

---

Therapeutic Pulmonary Hygiene and Pharmacological Adjuncts

Pharmacological management of lower airway injury focuses on lysing fibrin casts, thinning secretions, and reversing reactive bronchospasm.

                 ┌──────────────────────────────────────────┐
                 │   EVIDENCE-BASED INHALED AEROSOL REGIMEN │
                 └────────────────────┬─────────────────────┘
                                      │
             ┌────────────────────────┴────────────────────────┐
             ▼                                                 ▼
┌───────────────────────────────┐     ┌────────────────────────────────┐
│ AEROSOLIZED HEPARIN (q4h)     │     │ AEROSOLIZED NAC 20% (q4h)      │
│• 5,000–10,000 units in 3 mL NS│     │• 3–5 mL 20% solution           │
│• Inhibits thrombin conversion │     │• Cleaves disulfide bonds in    │
│  of fibrinogen to fibrin      │     │  mucus & cast proteins         │
│• Prevents new cast formation  │     │• Thins tenacious secretions    │
└────────────┬──────────────────┘     └────────────────┬───────────────┘
             │                                         │
             └────────────────────────┬────────────────┘
                                      ▼
                     ┌────────────────────────────────┐
                     │ INHALED BRONCHODILATORS        │
                     │• Albuterol (2.5 mg)            │
                     │• Ipratropium (0.5 mg)          │
                     │• Counters reactive spasm &     │
                     │  protects against NAC-spasm    │
                     └────────────────────────────────┘

1. Inhaled Aerosolized Unfractionated Heparin

• Mechanism: Inhaled heparin inhibits thrombin-mediated conversion of fibrinogen to fibrin on the denuded mucosal surface, directly halting the construction of the structural scaffold required for cast formation.
• Dosing: 5,000 to 10,000 units dissolved in 3 mL normal saline via nebulizer every 4 hours.
• Systemic Safety: Aerosolized heparin works locally on the pulmonary mucosa; systemic absorption is negligible, meaning it does not alter systemic coagulation parameters (PT/INR or aPTT) and does not increase surgical bleeding risk during burn debridement.

2. Inhaled Aerosolized N-Acetylcysteine (NAC)

• Mechanism: NAC is a potent mucolytic that hydrolyzes the disulfide bonds connecting mucoprotein molecules, dissolving thick mucus and loosening necrotic casts.
• Dosing: 3 to 5 mL of 20% solution (or 6–10 mL of 10% solution) nebulized every 4 hours, typically alternated with heparin.
• Precaution: NAC can induce reactive bronchospasm in hyperreactive airways. It must always be co-administered with or preceded by an inhaled beta-2 agonist.

3. Inhaled Bronchodilators

• Agents: Nebulized Albuterol (2.5 mg) and Ipratropium bromide (0.5 mg) administered every 4 to 6 hours.
• Purpose: Relieves severe smooth muscle bronchospasm induced by chemical toxins, decreases airway resistance, and enhances mucociliary and cough clearance.

4. Aggressive Physical Pulmonary Toilet

• Therapeutic Bronchoscopy: Performed as needed to mechanically visualize, irrigate, grasp, and aspirate large occlusive casts from lobar and segmental orifices.
• Chest Physiotherapy (CPT): High-frequency chest wall oscillation (the Vest), manual percussion/postural drainage, and early progressive out-of-bed mobilization.

---

Lung-Protective Mechanical Ventilation in Burn ARDS

Acute Respiratory Distress Syndrome (ARDS) develops in up to 30–50% of patients with severe inhalation injury combined with major cutaneous burns. Management requires strict adherence to evidence-based lung-protective ventilation.

[!IMPORTANT] Always Calculate Predicted Body Weight (PBW): Burn patients accumulate tens of kilograms of edema during resuscitation. Never set tidal volumes using the patient's actual recorded bed scale weight. Doing so causes massive volutrauma. Calculate PBW using standardized height and biological sex equations:

• Male PBW (kg): $50 + 0.91 \times (\text{Height in cm} - 152.4)$
• Female PBW (kg): $45.5 + 0.91 \times (\text{Height in cm} - 152.4)$

---

Advanced Ventilatory Modes and Rescue Strategies

When conventional lung-protective ventilation fails to maintain oxygenation or when endobronchial cast burden is severe, specialized modalities are utilized.

1. High-Frequency Percussive Ventilation (HFPV / Volara / VDR-4)

• Mechanism: HFPV delivers high-frequency sub-deadspace percussive breaths (rates of 200 to 600 cycles/min) superimposed on a standard low-frequency, pressure-controlled breathing cycle.
• Advantages in Inhalation Injury:
  • The percussive pressure waves travel down the core of the airway lumen, vibrating and shearing thick, adherent casts off the bronchial walls.
  • Exhaled gas moves along the outer circumference of the airway, sweeping loosened secretions and soot upward toward the trachea for easy suctioning.
  • Enhances diffusive gas exchange at low peak and mean airway pressures, minimizing barotrauma.

2. Prone Positioning in Burn ARDS

• Indication: Severe ARDS with a $\text{PaO}_2 / \text{FiO}_2$ ratio < 150 despite optimization of PEEP and recruitment.
• Mechanism: Prone positioning (for ≥ 16 consecutive hours daily) unweights the dorsal lung segments, homogenizes pleural pressure gradients, dramatically reduces V/Q mismatch, and improves drainage of secretions.
• Burn Nursing Considerations: Prone positioning in major burns requires meticulous coordination: protecting autografts and donor sites from shear stress, rigorous facial foam padding to prevent orbital compartment syndrome and pressure ulcers, and securing the ETT to prevent catastrophic accidental extubation during rotation.